Everything You Need to Know About Baby Aspirin for Cancer

Aspirin, one of the world’s oldest and most widely used medications, is no longer just for headaches or heart health. In low doses (commonly known as “baby aspirin”, 75–100 mg/day), it’s gaining recognition for its powerful role in cancer prevention, recurrence reduction, and metabolic therapy protocols. Aspirin works by reducing systemic inflammation, suppressing COX-2, and […]
Everything You Need to Know About Niclosamide for Cancer

Niclosamide is a decades-old antiparasitic drug originally used to treat tapeworm infections. But today, it’s being repurposed for a much bigger battle—cancer. With its ability to block multiple cancer-driving pathways simultaneously, Niclosamide is now seen as a broad-spectrum metabolic disruptor in oncology research. It doesn’t just target one mechanism—it hits cancer where it’s most vulnerable: […]
Everything You Need to Know About Methylene Blue for Cancer

Methylene Blue (MB) is a century-old compound originally used as a dye and treatment for malaria. Today, it’s gaining serious attention as a metabolic therapy tool in cancer due to its unique effects on mitochondrial function, oxidative stress, and cellular energy production. Unlike conventional drugs that aim to destroy cancer cells through toxicity, Methylene Blue […]
Everything You Need to Know About Metformin for Cancer

Metformin, one of the most widely prescribed medications for Type 2 diabetes, is now being recognized for its anti-cancer properties. Originally used to lower blood sugar and improve insulin sensitivity, Metformin is now under intense study for its ability to target cancer metabolism, growth pathways, and therapy resistance. In metabolic therapy protocols, Metformin’s value lies […]
Everything You Need to Know About LDN for Cancer

Low Dose Naltrexone (LDN) is gaining global recognition as one of the most promising low-toxicity tools in integrative cancer protocols. Originally developed as a treatment for opioid addiction at high doses, when used in small doses (1–4.5 mg), LDN exhibits powerful immune-modulating and anti-inflammatory effects—particularly relevant in cancer prevention and recovery. LDN has been shown […]
Everything You Need to Know About Doxycycline for Cancer

Doxycycline is a widely used antibiotic, commonly prescribed for respiratory infections, acne, and Lyme disease. But beyond its antimicrobial use, Doxycycline is emerging as a potent repurposed drug in cancer therapy—particularly in metabolic and mitochondrial-based strategies. What makes it powerful is that it doesn’t just fight bacteria—it targets the mitochondria of cancer cells, disrupts their […]
Everything You Need to Know About Itraconazole for Cancer

Itraconazole is widely known as an antifungal medication used to treat infections like athlete’s foot and fungal nail issues. But in recent years, this well-established drug has gained powerful attention in the field of cancer therapy. Research now shows that Itraconazole is more than just an antifungal. It exhibits strong anti-angiogenic, anti-proliferative, and signaling-disrupting effects […]
Everything You Need to Know About Mebendazole for Cancer

Mebendazole is best known as a safe, over-the-counter antiparasitic used to treat intestinal worms. But in recent years, it has gained global attention as one of the most promising repurposed drugs for cancer therapy. Researchers have discovered that Mebendazole doesn’t just target parasites—it also interferes with cancer cell division, tumor angiogenesis, and inflammation, making it […]
Everything You Need to Know About Fenbendazole for Cancer

Fenbendazole was never intended to be a cancer treatment. It’s an anti-parasitic drug used for deworming dogs. But over the last few years, it’s become one of the most talked-about repurposed medicines in the integrative cancer world—and for good reason. Despite its humble veterinary origins, fenbendazole has demonstrated powerful anticancer properties in preclinical studies and […]
Everything You Need to Know About Ivermectin for Cancer

Ivermectin was once known only as a humble antiparasitic drug—used to treat river blindness and intestinal worms. But today, it’s emerging as one of the most promising repurposed drugs in the fight against cancer. What began as curiosity is now supported by a growing body of scientific research, preclinical trials, and real-world case reports. Across […]